BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33755944)

  • 1. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt.
    Zhai XQ; Meng FM; Hu SF; Sun P; Xu W
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2155. PubMed ID: 33755944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2158. PubMed ID: 33755947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
    Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2462. PubMed ID: 33829425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2156. PubMed ID: 33755945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
    Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7919. PubMed ID: 32767312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2159. PubMed ID: 33755958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 affects the apoptosis of brain vascular endothelial cells and ROS production through regulating PI3K/AKT signaling pathway.
    Wang SW; Deng LX; Chen HY; Su ZQ; Ye SL; Xu WY
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4647. PubMed ID: 34337709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.
    Zang RK; Ma JB; Liang YC; Wang Y; Hu SL; Zhang Y; Dong W; Zhang W; Hu LK
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2457. PubMed ID: 33829426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
    Lei Y; Wang YH; Wang XF; Bai J
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2460. PubMed ID: 33829423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2157. PubMed ID: 33755946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2826. PubMed ID: 33877677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
    Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2154. PubMed ID: 33755943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway.
    Jiang YL; Liu WW; Wang Y; Yang WY
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):2. PubMed ID: 33506881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10920. PubMed ID: 33215404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG16 promotes migration and invasion through suppression of CDKN1A in clear cell renal cell carcinoma.
    Liu SB; Wang HF; Xie QP; Li G; Zhou LB; Hu B
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7216. PubMed ID: 32706054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647.
    Qian C; Liao CH; Tan BF; Chen YF; Dang BW; Chen JL; Liu CB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8628. PubMed ID: 32964947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
    Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):2828. PubMed ID: 33877685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7203. PubMed ID: 32706041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
    Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3150. PubMed ID: 33928597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA OR3A4 promotes metastasis of ovarian cancer via inhibiting KLF6.
    Guo FF; Jiang MM; Hong LL; Qiao B; Lin XM; Xu WY; Fu XQ
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7913. PubMed ID: 32767356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.